Brokerages Set Greenbrook TMS Inc. (NASDAQ:GBNH) Price Target at $16.10

Greenbrook TMS Inc. (NASDAQ:GBNH – Get Rating) has earned a consensus rating of “Buy” from the eight ratings firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and six have given a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $16.10.

Several equities research analysts have weighed in on GBNH shares. Bloom Burton restated a “buy” rating on shares of Greenbrook TMS in a research note on Monday, April 4th. Zacks Investment Research downgraded shares of Greenbrook TMS from a “hold” rating to a “sell” rating in a research note on Friday. Canaccord Genuity Group downgraded shares of Greenbrook TMS to a “buy” rating in a research note on Monday, February 7th. Finally, Clarus Securities lowered their target price on shares of Greenbrook TMS from C$8.25 to C$7.50 in a research note on Monday, April 4th.

GBNH stock remained flat at $$2.87 during trading on Friday. 3,445 shares of the company traded hands, compared to its average volume of 16,927. The stock’s 50-day moving average price is $3.25 and its two-hundred day moving average price is $4.79. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 2.26. Greenbrook TMS has a 12 month low of $2.73 and a 12 month high of $13.89.

Greenbrook TMS (NASDAQ:GBNH – Get Rating) last issued its quarterly earnings data on Wednesday, March 30th. The company reported ($0.34) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.38) by $0.04. Greenbrook TMS had a negative net margin of 47.42% and a negative return on equity of 189.28%. During the same quarter last year, the business earned ($0.60) EPS. Analysts anticipate that Greenbrook TMS will post -1.21 EPS for the current fiscal year.

Several large investors have recently bought and sold shares of GBNH. Royal Bank of Canada lifted its position in Greenbrook TMS by 243.1% during the third quarter. Royal Bank of Canada now owns 6,848 shares of the company’s stock valued at $51,000 after purchasing an additional 4,852 shares during the period. AdvisorShares Investments LLC acquired a new position in Greenbrook TMS during the third quarter valued at $103,000. Rockefeller Capital Management L.P. acquired a new position in Greenbrook TMS during the third quarter valued at $109,000. Virtu Financial LLC acquired a new position in Greenbrook TMS during the fourth quarter valued at $288,000. Finally, Royce & Associates LP lifted its position in Greenbrook TMS by 8.0% during the fourth quarter. Royce & Associates LP now owns 223,500 shares of the company’s stock valued at $977,000 after purchasing an additional 16,598 shares during the period. Institutional investors and hedge funds own 16.73% of the company’s stock.

Greenbrook TMS Company Profile (Get Rating)

Greenbrook Tms, Inc engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada.

Recommended Stories